辅助性T细胞17/调节性T细胞在类风湿关节炎免疫调节中的作用

被引：25

作者：

李忱

刘晋河

董振华

机构：

[1] 中国医学科学院北京协和医学院北京协和医院中医科

来源：

协和医学杂志 | 2016年 / 7卷 / 01期

关键词：

辅助性T细胞17; 调节性T细胞; 免疫调节; 类风湿关节炎;

D O I：

暂无

中图分类号：

R593.2 [自身免疫性疾病、结缔组织疾病];

学科分类号：

100201 [内科学];

摘要：

<正>辅助性T细胞17(T helper cell 17,Th17)和调节性T细胞(regulatory T cells,Treg)是近年来发现的两类CD4+T细胞亚群,目前认为Th17具有明显促进炎症的作用,引起组织炎性病理损伤;而Treg细胞具有抑制免疫反应的作用,维持机体的免疫耐受,两者对立统一,维持着机体平衡。Th17/Treg细胞平衡在自身免疫性疾病,尤其是类风湿关节炎免疫调节中

引用

页码：53 / 56

页数：4

共 10 条

[1]

Can IL-6 blockade rectify imbalance between Tregs and Th17 cells? [J].

Tanaka, Toshio .

IMMUNOTHERAPY, 2013, 5 (07) :695-697

[2]

Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of treg cells [J].

Ju, Ji Hyeon ;

Heo, Yu-Jung ;

Cho, Mi-La ;

Jhun, Joo-Yeon ;

Park, Jin-Sil ;

Lee, Seon-Yeong ;

Oh, Hye-Jwa ;

Moon, Su-Jin ;

Kwok, Seung-Ki ;

Park, Kyung-Su ;

Park, Sung-Hwan ;

Kim, Ho-Youn .

ARTHRITIS AND RHEUMATISM, 2012, 64 (11) :3543-3552

[3]

Th17 cells are restrained by Treg cells via the inhibition of interleukin‐6 in patients with rheumatoid arthritis responding to anti–tumor necrosis factor antibody therapy.[J].Jenny L. McGovern;Dao X. Nguyen;Clare A. Notley;Claudia Mauri;David A. Isenberg;Michael R. Ehrenstein.Arthritis & Rheumatism.2012, 10

[4]

Different effects of biological drugs in rheumatoid arthritis.[J].Fabiola Atzeni;Maurizio Benucci;Salvatore Sallì;Sara Bongiovanni;Laura Boccassini;Piercarlo Sarzi-Puttini.Autoimmunity Reviews.2012,

[5]

The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis [J].

Wang, Wenhong ;

Shao, Shihe ;

Jiao, Zhijun ;

Guo, Mingquan ;

Xu, Huaxi ;

Wang, Shengjun .

RHEUMATOLOGY INTERNATIONAL, 2012, 32 (04) :887-893

[6]

Therapeutic potential of Tregs to treat rheumatoid arthritis [J].

Wright, Graham P. ;

Stauss, Hans J. ;

Ehrenstein, Michael R. .

SEMINARS IN IMMUNOLOGY, 2011, 23 (03) :195-201

[7]

Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets [J].

Aravena, Octavio ;

Pesce, Barbara ;

Soto, Lilian ;

Orrego, Natalia ;

Sabugo, Francisca ;

Wurmann, Pamela ;

Carmen Molina, Maria ;

Alfaro, Jorge ;

Cuchacovich, Miguel ;

Carlos Aguillon, Juan ;

Catalan, Diego .

IMMUNOBIOLOGY, 2011, 216 (12) :1256-1263

[8]

LY2439821; a humanized anti–interleukin‐17 monoclonal antibody; in the treatment of patients with rheumatoid arthritis: A phase I randomized; double‐blind; placebo‐controlled; proof‐of‐concept study.[J].M. C.Genovese;F.Van den Bosch;S. A.Roberson;S.Bojin;I. M.Biagini;PeterRyan;J.Sloan‐Lancaster.Arthritis & Rheumatism.2010, 4

[9]

CD4<sup>+</sup> CD25<sup>+</sup> T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis.[J].M. Möttönen;J. Heikkinen;L. Mustonen;P. Isomäki;R. Luukkainen;O. Lassila.Clinical & Experimental Immunology.2005, 2

[10]

CD4+CD25+ regulatory T cells in rheumatoid arthritis - Differences in the presence, phenotype, and function between peripheral blood and synovial fluid [J].

van Amelsfort, JMR ;

Jacobs, KMG ;

Bijlsma, JWJ ;

Lafeber, FPJG ;

Taams, LS .

ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2775-2785

← 1 →